{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:49:45Z","timestamp":1788058185848,"version":"build-2784847793"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective\/Background:<\/jats:title>\n                    <jats:p>Neurological complications occur at a high frequency after hematopoietic cell transplantation (HCT). However, an absence is noted in the published literature as regards the quantification of the exact burden and the outcomes thereof. In this systematic review, we endeavored to detail if the recipients of HCT developed any noninfectious neurological events\/complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>According to the PICO criteria, medical literature was searched. Complications that were evaluated included: stroke, peripheral neuropathy, myasthenia gravis, seizures, and posterior reversible encephalopathy syndrome. After strictly defining relevant variables and parameters, data from 173 eligible articles were then extracted accordingly, from the full text for each, for quantitative analysis; additionally, two American Society of Hematology conference abstracts were also subject to data extraction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>As is evident from the results of the data analysis, an increased frequency of these complications was seen in the HCT recipient population in comparison to the general population. The relative risk ranged from 1.33\u00d7 to 142\u00d7 depending on the complication studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>These findings demonstrate that the recipients of HCT had a significantly higher risk of neurological complications and that their early recognition can enhance the monitoring of HCT survivors for the early developmental signs of neurological toxicity. This would facilitate timely interventions, thus ensuring a better quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.hemonc.2020.05.006","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T21:40:59Z","timestamp":1590010859000},"page":"87-94","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Noninfectious neurologic complications of hematopoietic cell transplantation"],"prefix":"10.4103","volume":"14","author":[{"given":"Mohammad Abdurrehman","family":"Sheikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sairah","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zartash","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrukh K.","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20241211","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.pop.2016.07.003","article-title":"Basics of hematopoietic cell transplantation for primary care physicians and internists","volume":"43","author":"Hashmi","year":"2016","journal-title":"Prim Care"},{"key":"R2-1-20241211","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/bmt.2013.51","article-title":"Hematopoietic SCT in Europe: Data and trends in 2011","volume":"48","author":"Passweg","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"R3-1-20241211","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1182\/blood-2017-03-772368","article-title":"Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States","volume":"130","author":"Muffly","year":"2017","journal-title":"Blood"},{"key":"R4-1-20241211","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1002\/cncr.30770","article-title":"Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma","volume":"123","author":"Veltri","year":"2017","journal-title":"Cancer"},{"key":"R6-1-20241211","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1182\/blood-2010-05-280883","article-title":"Systematic review and meta-analysis methodology","volume":"116","author":"Crowther","year":"2010","journal-title":"Blood"},{"key":"R7-1-20241211","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.2014.5559","article-title":"How to read a systematic review and metaanalysis and apply the results to patient care: Users\u2019 guides to the medical literature","volume":"312","author":"Murad","year":"2014","journal-title":"JAMA"},{"key":"R13-1-20241211","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.62.4.310","article-title":"Epidemiology of peripheral neuropathy","volume":"62","author":"Martyn","year":"1997","journal-title":"J Neurol Neurosurg Psych"},{"key":"R14-1-20241211","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000007998","article-title":"Neurological complications after autologous stem cell transplantation","volume":"41","author":"Guerrero","year":"1999","journal-title":"Eur Neurol"},{"key":"R15-1-20241211","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/TP.0000000000001257","article-title":"Neurological complications involving the central nervous system after allogeneic hematopoietic stem cell transplantation during a period of evolution in transplant modalities: A cohort analysis","volume":"101","author":"Colombo","year":"2017","journal-title":"Transplantation"},{"key":"R16-1-20241211","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/sj.bmt.1704749","article-title":"Life-threatening neurological complications after bone marrow transplantation in children","volume":"35","author":"Uckan","year":"2005","journal-title":"Bone Marrow Transp"},{"key":"R17-1-20241211","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.bbmt.2009.07.013","article-title":"Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation","volume":"15","author":"Barba","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"R18-1-20241211","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1212\/01.wnl.0000247038.43228.17","article-title":"Spectrum and prognosis of neurologic complications after hematopoietic transplantation","volume":"67","author":"Denier","year":"2006","journal-title":"Neurology"},{"key":"R19-1-20241211","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.bbmt.2007.07.013","article-title":"Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance","volume":"13","author":"Siegal","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"R20-1-20241211","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1212\/01.WNL.0000046522.38465.79","article-title":"Prospective evaluation of neurological complications after allogeneic bone marrow transplantation","volume":"60","author":"Sostak","year":"2003","journal-title":"Neurology"},{"key":"R21-1-20241211","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1212\/WNL.50.5.1441","article-title":"Early neurologic complications following allogeneic bone marrow transplant for leukemia: a prospective study","volume":"50","author":"Antonini","year":"1998","journal-title":"Neurology"},{"key":"R22-1-20241211","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/brain\/124.5.1043","article-title":"Stroke after bone marrow transplantation: frequency, aetiology and outcome","volume":"124","author":"Coplin","year":"2001","journal-title":"Brain"},{"key":"R23-1-20241211","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1590\/S0004-282X2008000500014","article-title":"Neurological complications of hematopoietic stem cell transplantation (HSCT): a retrospective study in a HSCT center in Brazil","volume":"66","author":"Teive","year":"2008","journal-title":"Arq Neuropsiquiatr"},{"key":"R24-1-20241211","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3324\/haematol.2012.069559","article-title":"Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients","volume":"98","author":"Labrador","year":"2013","journal-title":"Haematologica"},{"key":"R25-1-20241211","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/sj.bmt.1703315","article-title":"Intracranial hemorrhage following bone marrow transplantation: an autopsy study of 58 patients","volume":"29","author":"Bleggi-Torres","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"R26-1-20241211","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1212\/WNL.46.4.1004","article-title":"Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study","volume":"46","author":"Graus","year":"1996","journal-title":"Neurology"},{"key":"R27-1-20241211","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood.V122.21.3322.3322","article-title":"Intracranial hemorrhage and mortality in 1461 patients after allogeneic hematopoietic stem cell transplantation for 6-year follow-up: Study of 44 cases","volume":"122","author":"Zhang","year":"2013","journal-title":"Blood"},{"key":"R28-1-20241211","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00007890-200211150-00018","article-title":"Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients","volume":"74","author":"Pihusch","year":"2002","journal-title":"Transplantation"},{"key":"R29-1-20241211","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1590\/S0004-282X1998000200017","article-title":"Peripheral neuropathy investigation in the early stage of bone marrow transplantation","volume":"56","author":"Z\u00e9tola","year":"1998","journal-title":"Arq Neuropsiquiatr"},{"key":"R30-1-20241211","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.bmt.1701575","article-title":"Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-disease","volume":"23","author":"Tse","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"R31-1-20241211","first-page":"649","article-title":"Myasthenia gravis after allogeneic bone marrow transplantation: a case report","volume":"15","author":"Zaja","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"R32-1-20241211","first-page":"155","article-title":"Myasthenia gravis after allogeneic bone marrow transplantation","volume":"14","author":"Shimoda","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"R33-1-20241211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4061\/2011\/474512","article-title":"Thymoma in myasthenia gravis: from diagnosis to treatment","volume":"2011","author":"Romi","year":"2011","journal-title":"Autoimmune Dis"},{"key":"R34-1-20241211","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1056\/NEJM198707163170314","article-title":"Antibodies against the acetylcholine receptor in hematologic disorders: implications for the development of myasthenia gravis after bone marrow grafting","volume":"317","author":"Lefvert","year":"1987","journal-title":"N Engl J Med"},{"key":"R35-1-20241211","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbmt.2013.10.028","article-title":"Risk of seizures in children receiving busulphan-containing regimens for stem cell transplantation","volume":"20","author":"Caselli","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"R36-1-20241211","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/archneur.65.12.1612","article-title":"Continuous electroencephalographic monitoring in critically ill patients with central nervous system infections","volume":"65","author":"Carrera","year":"2008","journal-title":"Arch Neurol"},{"key":"R37-1-20241211","first-page":"393","article-title":"Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin","volume":"8","author":"Reece","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"R38-1-20241211","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1399-0012.2009.01181.x","article-title":"Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation","volume":"24","author":"Yanagimachi","year":"2010","journal-title":"Clin Transplant"},{"key":"R39-1-20241211","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/01.HYP.18.4.458","article-title":"Cyclosporine causes sympathetically mediated elevations in arterial pressure in rats","volume":"18","author":"Morgan","year":"1991","journal-title":"Hypertension"},{"key":"R40-1-20241211","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(84)91556-3","article-title":"Association between cyclosporin neurotoxicity and hypomagnesaemia","volume":"2","author":"Thompson","year":"1984","journal-title":"Lancet"},{"key":"R41-1-20241211","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJM198710013171404","article-title":"Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol","volume":"317","author":"de Groen","year":"1987","journal-title":"N Engl J Med"},{"key":"R43-1-20241211","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bbmt.2016.12.632","article-title":"Neurologic complications after allogeneic hematopoietic stem cell transplantation","volume":"23","author":"Maffini","year":"2017","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Hematology\/Oncology and Stem Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658387620301047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658387620301047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/10.1016\/j.hemonc.2020.05.006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:48:50Z","timestamp":1787838530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1016\/j.hemonc.2020.05.006"}},"subtitle":["A systematic review"],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1016\/j.hemonc.2020.05.006","relation":{},"ISSN":["1658-3876"],"issn-type":[{"value":"1658-3876","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}